JP Morgan Maintains Underweight on M.D.C. Holdings, Lowers Price Target to $27.5
JP Morgan analyst Michael Rehaut maintains M.D.C. Holdings (NYSE:MDC) with a Underweight and lowers the price target from $30.5 to $27.5.
A Look Into Consumer Cyclical Sector Value Stocks
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the…
M.D.C. Holdings Q4 EPS $1.08 Misses $1.52 Estimate, Sales $1.48B Beat $1.33B Estimate
M.D.C. Holdings (NYSE:MDC) reported quarterly earnings of $1.08 per share which missed the analyst consensus estimate of $1.52 by 28.95 percent. This is a 54.04 percent decrease over earnings of $2.35 per share from the
Earnings Scheduled For January 31, 2023
Companies Reporting Before The Bell
• Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.
JP Morgan Downgrades M.D.C. Holdings to Underweight, Raises Price Target to $28
JP Morgan analyst Michael Rehaut downgrades M.D.C. Holdings (NYSE:MDC) from Neutral to Underweight and raises the price target from $27 to $28.
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell
• Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Raymond James Downgrades US Homebuilders On Mortgage Rate Hike
Raymond James analyst Buck Horne lowered the rating on the shares of KB Home (NYSE:KBH), Lennar Corp (NYSE:LEN), M.D.C. Holdings Inc (NYSE:MDC), PulteGroup Inc (NYSE:PHM), and Toll Brothers…
Looking Into M.D.C. Holdings’s Return On Invested Capital
According to Benzinga Pro, during Q2, M.D.C. Holdings (NYSE:MDC) earned $189.54 million, a 27.71% increase from the preceding quarter. M.D.C. Holdings also posted a total of $1.49 billion in sales, a 17.09% increase since Q1. In Q1, M.D.C.
M.D.C. Holdings: Q2 Earnings Insights
M.D.C. Holdings (NYSE:MDC) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.